|
E2F4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.371810E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.121600E-02 |
| Normal-vs-Stage2 |
4.199800E-01 |
| Normal-vs-Stage3 |
5.524500E-03 |
| Normal-vs-Stage4 |
1.878160E-01 |
| Stage1-vs-Stage2 |
5.159800E-01 |
| Stage1-vs-Stage3 |
1.712590E-01 |
| Stage1-vs-Stage4 |
8.572800E-01 |
| Stage2-vs-Stage3 |
1.826810E-01 |
| Stage2-vs-Stage4 |
5.970200E-01 |
| Stage3-vs-Stage4 |
5.935400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.811700E-02 |
| Normal-vs-AfricanAmerican |
4.184400E-01 |
| Normal-vs-Asian |
2.349200E-01 |
| Caucasian-vs-AfricanAmerican |
6.565600E-01 |
| Caucasian-vs-Asian |
7.819800E-01 |
| AfricanAmerican-vs-Asian |
8.180600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.594000E-02 |
| Normal-vs-Female |
2.474000E-02 |
| Male-vs-Female |
5.680000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.787800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.757520E-02 |
| Normal-vs-Age(61-80Yrs) |
8.679700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.960000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.249400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.263200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.956000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.774600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.328400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.298000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.406250E-02 |
| Classical-VS-Follicular |
9.518000E-02 |
| Classical-VS-Other |
1.742820E-01 |
| Classical-VS-Normal |
1.648170E-01 |
| Tall-VS-Follicular |
3.363400E-01 |
| Tall-VS-Other |
9.260600E-01 |
| Tall-VS-Normal |
1.097590E-03 |
| Follicular-VS-Other |
5.565800E-01 |
| Follicular-VS-Normal |
1.636200E-02 |
| Other-VS-Normal |
3.811700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.610500E-02 |
| Normal-vs-N1 |
7.658100E-02 |
| N0-vs-N1 |
5.750800E-01 |
|
|
